Regulation of Maternal-fetal Metabolic Communication
Overview
Affiliations
Pregnancy may be the most nutritionally sensitive stage in the life cycle, and improved metabolic health during gestation and early postnatal life can reduce the risk of chronic disease in adulthood. Successful pregnancy requires coordinated metabolic, hormonal, and immunological communication. In this review, maternal-fetal metabolic communication is defined as the bidirectional communication of nutritional status and metabolic demand by various modes including circulating metabolites, endocrine molecules, and other secreted factors. Emphasis is placed on metabolites as a means of maternal-fetal communication by synthesizing findings from studies in humans, non-human primates, domestic animals, rabbits, and rodents. In this review, fetal, placental, and maternal metabolic adaptations are discussed in turn. (1) Fetal macronutrient needs are summarized in terms of the physiological adaptations in place to ensure their proper allocation. (2) Placental metabolite transport and maternal physiological adaptations during gestation, including changes in energy budget, are also discussed. (3) Maternal nutrient limitation and metabolic disorders of pregnancy serve as case studies of the dynamic nature of maternal-fetal metabolic communication. The review concludes with a summary of recent research efforts to identify metabolites, endocrine molecules, and other secreted factors that mediate this communication, with particular emphasis on serum/plasma metabolomics in humans, non-human primates, and rodents. A better understanding of maternal-fetal metabolic communication in health and disease may reveal novel biomarkers and therapeutic targets for metabolic disorders of pregnancy.
Van Willigen B, van der Hout-van der Jagt M, Huberts W, van de Vosse F Int J Numer Method Biomed Eng. 2024; 41(1):e3881.
PMID: 39625422 PMC: 11661441. DOI: 10.1002/cnm.3881.
The role of epigenetics in women's reproductive health: the impact of environmental factors.
Yu X, Xu J, Song B, Zhu R, Liu J, Liu Y Front Endocrinol (Lausanne). 2024; 15:1399757.
PMID: 39345884 PMC: 11427273. DOI: 10.3389/fendo.2024.1399757.
Luo Y, Wang Z, Zhao X, Xing J, Chen Z, Zhao W Metabolites. 2024; 14(9).
PMID: 39330476 PMC: 11434538. DOI: 10.3390/metabo14090469.
Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review.
Formisano E, Proietti E, Perrone G, Demarco V, Galoppi P, Stefanutti C Nutrients. 2024; 16(17).
PMID: 39275243 PMC: 11397408. DOI: 10.3390/nu16172927.
Lv W, Xie H, Wu S, Dong J, Jia Y, Ying H Front Endocrinol (Lausanne). 2024; 15:1440436.
PMID: 39229380 PMC: 11368757. DOI: 10.3389/fendo.2024.1440436.